High Precision Zinc Isotopic Measurements Applied to Mouse Organs
May 22nd, 2015
We present the technique to measure with high precision zinc isotope ratios in mouse organs.
The overall goal of this procedure is to measure zinc isotope ratios in mouse organs with high precision. This is accomplished by first dissolving the different organs and acids to free all the atoms in solution, followed by solution of aberration, the dried material is then resuspended in hydrogen bromide ion exchange chromatography is then used to purify the zinc from all the other elements of the sample using a conditioned gravity column. Zinc is alluded from the resin using nitric acid.
The final step is to measure the zinc isotope ratios using a multi collection inductively coupled plasma mass spectrometer. Ultimately, the isotopic composition is used to diagnose diseases that modify the zinc balance of the body through measuring the equilibrium distribution of zinc isotopes in different organs. So this method has been developed to provide insight into the natural distribution ation and transport mechanisms of zinc between mouse organs.
It can be applied to any animal, and it can ultimately be used to diagnose diseases that modifies the balance of zinc between organs such as Alzheimer's disease. Begin this procedure with preparation of the materials and the sample as detailed in the text protocol to perform chemical purification work in a fume hood to make a mixture of approximately one milliliter of 30%hydrogen peroxide and approximately one milliliter of concentrated nitric acid. Place the whole organ of interest into a 15 milliliter Teflon beaker.
Then add the mixture to the beaker. Keep the beaker open for a few minutes in order to avoid splashes due to the reaction of oxidation of the organic matter and the release of carbon dioxide. Finally, put the beaker on a hot plate at about 100 degrees Celsius for a couple of hours or until the solution is perfectly clear.
Next, open the beaker and dry the solution on a hot plate at about 100 degrees Celsius. Once the sample is dry, add one milliliter of hydrogen bromide to the sample. Close the beaker and let it dissolve on a hot plate at 100 degrees Celsius for a couple of hours.
Meanwhile, prepare the 500 microliter columns. Add 500 microliters of the Ag one x 8 200 400 mesh resin to the column and put it on the column rack with a trash beaker Below it. Wash the resin by alternating five milliliters of 18.2 mega ohm centimeter water and five milliliters of 0.5 normal nitric acid two times, then wash with five milliliters of water.
Finally condition the resin with five milliliters of hydrogen bromide. Next, remove the beaker from the hot plate and put it in an ultrasonic bath For about 30 minutes, allow the beaker to cool down to room temperature. Once the beaker is cooled and the resin is washed, open the beaker.
Put the tip adapter to the syringe and add a pipette tip. Then pipette one milliliter of the sample and load it onto the resin very slowly in order not to agitate the resin. Once all the liquid passes through the column, add five milliliters of hydrogen bromide.
Allow the hydrogen bromide to pass through the column and then replace the trash beaker with a clean 15 milliliter beaker. Then add five milliliters of nitric acid, 2.5 milliliters at a time. At this stage, the zinc isud from the resin.
Once the nitric acid passes through the column, remove the beaker and place it on a hot plate at 100 degrees Celsius until dried. Remove the column from the column holder and discard the resin. Once the sample is dry, repeat the protocol with the same volume of acids on a smaller 100 microliter column and then place it on a hot plate until dried.
The sample is now ready for mass spectrometry. Analyze the zinc isotopic composition on a multi collector inductively coupled plasma mass spectrometer. Set up the machine using the parameters summarized in the text protocol.
Position the Faraday cups to collect at the mast to charge ratio of nickel 62, copper 63, zinc 64, copper 65, zinc 66, zinc 67, and zinc 68. Next, analyze a 500 parts per billion solution of zinc in 0.1 molar nitric acid by using a spray chamber combined with a 100 microliter per minute Teflon nebulizer. For each sample, measure 30 scans in which the integration time of each scan is 8.389 seconds.
Correct the background by subtracting the on-peak zero intensities from a blank solution control and correct possible nickel 64 ISO baric interference. By measuring the intensity of the nickel 62 peak, assume that the nickel 64 to nickel 62 ratio is natural. Correct this value from the instrumental mass bias, and then remove the nickel 64 on the mass 64 as described in the text protocol, correct the instrumental mass bias by bracketing each of the samples with a 500 parts per billion standard solution of the JMC Leon Zinc standard.Shown.
Here are typical results obtained with this method as a three isotope plot of Delta Zinc 68 versus Delta Zinc 66. For different organs, all the organs fall on a slope two line. This shows that the isotopic fractionation is mass dependent mouse organs are isotopically distinct.
Interestingly, red blood cells and bones are enriched in delta Zinc 66 when compared to serum brain and liver. This fractionation is well explained by the equilibrium distribution of isotopes between different bonding environments of zinc in different organs. After watching the video, you should have a good understanding of how to obtain high precision zinc isotopic measurements of mouse organs.
Don't forget that the main difficulty is to avoid contamination of your sample with external zinc, and it is for essential to work in a clean laboratory and to use high periodic chemical regions.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a technique for measuring zinc isotope ratios in mouse organs with high precision. The method involves dissolving organs, purifying zinc, and analyzing isotopic composition to understand zinc distribution and transport mechanisms.
Key Study Components
Area of Science
- Neuroscience
- Biochemistry
- Metallomics
Background
- Zinc plays a crucial role in various biological processes.
- Isotope ratios can provide insights into metabolic states.
- Understanding zinc distribution is important for diagnosing diseases.
- Mouse models are commonly used for biological research.
Purpose of Study
- To measure zinc isotope ratios in mouse organs.
- To provide insights into zinc transport mechanisms.
- To aid in diagnosing diseases affecting zinc balance.
Methods Used
- Dissolving mouse organs in acids.
- Using ion exchange chromatography for zinc purification.
- Eluting zinc from resin with nitric acid.
- Measuring isotope ratios with a mass spectrometer.
Main Results
- High precision in measuring zinc isotope ratios achieved.
- Insights into the natural distribution of zinc in organs.
- Methodology supports disease diagnosis related to zinc imbalance.
- Enhanced understanding of zinc transport mechanisms.
Conclusions
- The technique provides valuable data for neuroscience research.
- It can be applied to study various diseases.
- Future research can build on these findings to explore zinc's role in health.
Frequently Asked Questions
Executive Industry Relevance
High-precision zinc isotope ratio measurement enables mechanistic de-risking in target validation by revealing organ-specific zinc distribution patterns. This approach supports predictive confidence in preclinical models by linking isotopic fractionation to disease-related zinc imbalance. The method provides translational biomarker potential for diseases involving disrupted zinc homeostasis, such as neurodegenerative disorders.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through quantification of zinc isotope ratios as functional readouts of organ-specific zinc metabolism.
- Operational Value: Provides a standardized, contamination-controlled workflow for isolating zinc from complex biological matrices using anion-exchange chromatography.
- Predictive Value: Supports biological de-risking by identifying isotopic signatures that reflect equilibrium distribution of zinc across different bonding environments in vivo.
Screening & Assay Development
- Scientific Value: Delivers quantitative, mass-dependent isotopic measurements (e.g., delta Zn-66, delta Zn-68) that serve as high-fidelity readouts for compound-induced shifts in zinc trafficking.
- Operational Value: Ensures assay reproducibility through standard bracketing and correction for instrumental mass bias, achieving 50 ppm (2 s.d.) precision.
- Platform Utility: Enables scalable screening of zinc-modulating compounds using mouse organs as disease-relevant systems with isotopic readouts.
Translational & Preclinical Research
- Scientific Value: Facilitates mechanistic de-risking by connecting isotopic fractionation in organs (e.g., enrichment in red blood cells and bone) to altered zinc transport in disease models.
- Translational Continuity: Supports biomarker alignment by demonstrating organ-specific isotopic signatures that correlate with physiological states, enabling cross-species extrapolation.
- Risk-Adjusted Advancement: Informs go/no-go decisions by detecting early perturbations in zinc homeostasis before phenotypic manifestation.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through preclinical profiling, where isotopic readouts inform mechanism of action and target engagement for zinc-modulating therapeutics.
- Discovery Biology: Supports hypothesis testing by revealing how genetic or pharmacological perturbations alter zinc isotope partitioning across organs.
- Screening: Enables assay readiness through purified zinc fractions suitable for high-precision MC-ICP-MS analysis with minimal isobaric interference.
- Analytics: Generates isotopic ratio outputs (δ⁶⁶Zn, δ⁶⁸Zn) that allow quantitative comparison of zinc flux under varying experimental conditions.
- Translational Research: Connects discovery findings to preclinical continuity by identifying isotopic biomarkers of zinc dysregulation applicable to disease modeling.
- Enterprise Reuse: Establishes a reusable platform for isotopic profiling across therapeutic areas involving metallobiology, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing ambiguity in zinc-mediated mechanisms through direct isotopic measurement.
- Operational Value: Ensures standardization and reproducibility via clean laboratory protocols, high-purity reagents, and mass bias correction using standard bracketing.
- Strategic Value: Improves capital efficiency by enabling early detection of off-target zinc effects, reducing late-stage attrition due to unanticipated metallobiological toxicity.
- Portfolio Impact: Supports risk-adjusted prioritization by providing mechanistic biomarkers that reflect target engagement in zinc homeostasis pathways.
Implementation Considerations
- Requires expertise in trace metal chemistry and clean laboratory practices to prevent exogenous zinc contamination.
- Dependent on multi-collector ICP-MS instrumentation with capacity for low-resolution isotopic analysis and spray chamber introduction.
- Necessitates cross-team standardization of sample preparation, purification, and data correction protocols across discovery and preclinical groups.
- Involves adaptation considerations when extending the method to other model systems (e.g., rat, human tissue) due to variations in organ size and zinc concentration.
- Practical limitation: Long processing times due to multi-step dissolution, chromatography, and drying phases, which may constrain throughput in high-volume screening.
